Fludarabine, Cyclophosphamide, Ofatumumab (FC-O2) As Front-Line Treatment for Young and Fit Patients with Chronic Lymphocytic Leukemia (CLL): Preliminary Results of the Prospective Phase 2 LLC0911 Gimema Study

Mauro, Fr; Zaja, F; Molica, S; Coscia, M; Liberati, Am; Piciocchri, A; Ilariucci, F; Russo, F; Re, F; Tedeschi, A; Baraldi, A; Carella, Am; Gozzetti, A; Del Poeta, G; Cortelezzi, A; Battistini, R; Iannella, E; Ferretti, A; Del Giudice, I; Della Starza, I; Raponi, S; De Propris, Ms; Ilari, C; Cafforio, L; Nanni, M; Fazi, P; Vignetti, M; Neri, A; Specchia, G; Cuneo, A; Guarini, A; Foa, R